| Title: | A two-sample Mendelian randomization study explores metabolic profiling of different glycemic traits |
| Journal: | Communications Biology |
| Published: | 8 Mar 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/38459184/ |
| DOI: | https://doi.org/10.1038/s42003-024-05977-1 |
| URL: | https://www.nature.com/articles/s42003-024-05977-1.pdf |
| Citations: | 5 (5 in last 2 years) as of 8 Aug 2024 |
Publication 8527
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
We assessed the causal relation of four glycemic traits and type 2 diabetes liability with 167 metabolites using Mendelian randomization with various sensitivity analyses and a reverse Mendelian randomization analysis. We extracted instruments for fasting glucose, 2-h glucose, fasting insulin, and glycated hemoglobin from the Meta-Analyses of Glucose and Insulin-related traits Consortium (n = 200,622), and those for type 2 diabetes liability from a meta-analysis of multiple cohorts (148,726 cases, 965,732 controls) in Europeans. Outcome data were from summary statistics of 167 metabolites from the UK Biobank (n = 115,078). Fasting glucose and 2-h glucose were not associated with any metabolite. Higher glycated hemoglobin was associated with higher free cholesterol in small low-density lipoprotein. Type 2 diabetes liability and fasting insulin were inversely associated with apolipoprotein A1, total cholines, lipoprotein subfractions in high-density-lipoprotein and intermediate-density lipoproteins, and positively associated with aromatic amino acids. These findings indicate hyperglycemia-independent patterns and highlight the role of insulin in type 2 diabetes development. Further studies should evaluate these glycemic traits in type 2 diabetes diagnosis and clinical management.</p>
8 Authors
- Tommy H. T. Wong
- Jacky M. Y. Mo
- Mingqi Zhou
- Jie V. Zhao
- C. Mary Schooling
- Baoting He
- Shan Luo
- Shiu Lun Au Yeung
Enabling scientific discoveries that improve human health